Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

Published Date: 25 Dec 2024

Recent results from the Phase III NRG-RTOG 1112 clinical study showed that the addition of stereotactic body radiotherapy (SBRT) to systemic therapy with sorafenib significantly improved progression-free survival (PFS) and ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What Patients Hear From Us: 'Blah, Blah, Tumor, Blah, Blah, Cancer'

2.

Study finds higher breast cancer rates in areas with more air pollution

3.

Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

4.

Morning Immunotherapy Does Not Boost Lung Cancer Survival

5.

Sydney researchers identify new tools to improve cancer diagnosis and treatment.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot